

MongoDB vs Mettler Toledo
Popular cloud database platform for modern developers vs Global laboratory and industrial measurement equipment market leader. Which is the better buy for your portfolio in November 2026? Plain-English answer below.
MongoDB sells a developer-friendly NoSQL database platform at premium SaaS multiples while Mettler-Toledo manufactures precision instruments and scales that serve pharma, food, and chemical customers globally. Both companies protect fat gross margins through proprietary technology that customers find costly to rip out. The MongoDB vs Mettler Toledo comparison digs into how growth reinvestment versus operational discipline shapes long-run return profiles for two very different quality businesses.
MongoDB sells a developer-friendly NoSQL database platform at premium SaaS multiples while Mettler-Toledo manufactures precision instruments and scales that serve pharma, food, and chemical customers ...
Why It’s Moving

MongoDB Shares Rally Amid Analyst Bullishness and Upcoming Earnings
- Shares gained 2.8% to reach $341.36, marking a fourth consecutive winning session despite broader market volatility.
- A new analyst initiation on a bullish note coincided with MongoDB being listed among top growth stocks with a Strong Buy rating.
- The company confirmed it will report Q3 FY2027 financial results after market close on December 1, 2026, fueling anticipation for another potential earnings beat.

Mettler-Toledo Rallies on Q3 Beat and Raised 2026 Outlook
- Q3 adjusted EPS came in at $12.57, marking a 13% increase year-over-year and beating prior estimates, while reported sales grew 6% compared to the previous year.
- Management raised the full-year 2026 sales outlook following strong performance in Asian and other emerging markets, signaling sustained global demand for their precision instruments.
- The company recently hosted its Analyst/Investor Day and presented at the UBS Global Healthcare Conference, where leadership highlighted margin expansion and projected continued growth into 2027.

MongoDB Shares Rally Amid Analyst Bullishness and Upcoming Earnings
- Shares gained 2.8% to reach $341.36, marking a fourth consecutive winning session despite broader market volatility.
- A new analyst initiation on a bullish note coincided with MongoDB being listed among top growth stocks with a Strong Buy rating.
- The company confirmed it will report Q3 FY2027 financial results after market close on December 1, 2026, fueling anticipation for another potential earnings beat.

Mettler-Toledo Rallies on Q3 Beat and Raised 2026 Outlook
- Q3 adjusted EPS came in at $12.57, marking a 13% increase year-over-year and beating prior estimates, while reported sales grew 6% compared to the previous year.
- Management raised the full-year 2026 sales outlook following strong performance in Asian and other emerging markets, signaling sustained global demand for their precision instruments.
- The company recently hosted its Analyst/Investor Day and presented at the UBS Global Healthcare Conference, where leadership highlighted margin expansion and projected continued growth into 2027.
Investment Analysis

MongoDB
MDB
Pros
- MongoDB is a leading provider in the rapidly growing NoSQL database market with strong cloud adoption potential.
- The company has demonstrated consistent revenue growth driven by subscription sales and expanding customer base.
- MongoDB’s Atlas cloud platform is a key growth driver, offering scalable database-as-a-service solutions.
Considerations
- MongoDB faces intense competition from established database providers and cloud giants offering their own database services.
- High operational costs and investments in R&D impact short-term profitability.
- Reliance on cloud platform growth exposes the company to potential risks from cloud service outages or pricing pressures.
Pros
- Mettler-Toledo is a market leader in precision instruments with strong global diversification across America, Europe, and Asia.
- The company has shown steady earnings growth with a projected 7-10% annual EPS increase in the near term.
- Robust profit margins driven by premium product offerings and demand in pharmaceutical and food sectors support financial health.
Considerations
- The stock trades at a high price-to-earnings ratio, indicating a premium valuation that might limit near-term upside.
- Growth is moderately dependent on market expansion in regulated industries, which may face cyclical or regulatory headwinds.
- Relatively low dividend yield and medium financial health scores could concern income-focused investors.
MongoDB (MDB) Next Earnings Date
The next confirmed earnings date for MDB is December 1, 2026, scheduled to release after market close. This report will cover the company's fiscal third quarter results. Investors should note that this timing aligns with the historical pattern of reporting approximately three months after the previous September release.
Mettler Toledo (MTD) Next Earnings Date
The next earnings date for MTD has not been confirmed yet. Based on the company's historical reporting pattern, which typically occurs approximately three months after the previous report, the expected timing is February 2027. This upcoming release will cover the fourth quarter of fiscal year 2026. Investors should monitor official announcements for the precise scheduling details.
MongoDB (MDB) Next Earnings Date
The next confirmed earnings date for MDB is December 1, 2026, scheduled to release after market close. This report will cover the company's fiscal third quarter results. Investors should note that this timing aligns with the historical pattern of reporting approximately three months after the previous September release.
Mettler Toledo (MTD) Next Earnings Date
The next earnings date for MTD has not been confirmed yet. Based on the company's historical reporting pattern, which typically occurs approximately three months after the previous report, the expected timing is February 2027. This upcoming release will cover the fourth quarter of fiscal year 2026. Investors should monitor official announcements for the precise scheduling details.
Buy MDB or MTD in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


